Overview

Study of Aripiprazole in Subjects With Alcoholism

Status:
Completed

Trial end date:
2005-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this clinical research study is to learn whether subjects treated with aripiprazole are able to abstain from alcohol use for a greater number of days than subjects treated with placebo. The safety of using aripiprazole will also be studied.

Phase:

Phase 4

Details

Lead Sponsor:

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborator:

Otsuka America Pharmaceutical

Treatments:

Aripiprazole